Pharma stocks rebound as tariff fears ease; Sun Pharma, Lupin, Cipla lead gains
Analysts said the sell-off last week was sentiment-driven, since US tariffs target branded and patented drugs while Indian exports are largely generic
Analysts said the sell-off last week was sentiment-driven, since US tariffs target branded and patented drugs while Indian exports are largely generic
What's Your Reaction?
:max_bytes(150000):strip_icc()/GettyImages-2187410260-5afe56694791404f99c253dd8d5abe6a.jpg?#)
